Introduction
A wide variety of naturally-occurring substances in edible plants possess substantial chemopreventive or chemoprotective activities. These are often attributed to their antioxidative and anti-inflammatory properties (Surh, 1999; Surh et al., 2001) . Curcumin (diferuloylmethane; structure shown in Fig. 1 ), a yellow pigment that is derived from turmeric (Curcuma longa L., Zingiberaceae), is protective against a wide range of experimentally-induced tumors. These include mammary, forestomach, duodenal, skin, and colon cancers (Nagabhushan et al., 1992; Huang et al., 1997; Samaha et al., 1997; Verma et al., 1997; Huang et al., 1998; Dorai et al., 2000) . The compound alleviates the 12-Otetradecanoylphorbol-13-acetate (TPA)-induced oxidative DNA damage in mouse epidermis (Huang et al., 1997) and cultured mouse fibroblast cells (Shih and Lin, 1993) , as well as superoxide production in macrophages (Ruby et al., 1995) . It also suppresses the expression of phospholipase, cyclooxygenase, and inducible nitric oxide synthase that are involved in mediating inflammatory responses (Huang et al., 1991; Rao et al., 1995; Pan et al., 2000) . Moreover, curcumin preferentially causes the apoptosis of several types of cancer cells (Jiang et al., 1996a,b; Kuo et al., 1996; Samaha et al., 1997; Shim et al., 2001) . For instance, curcumin inhibits the proliferation/growth of Jurkat T leukemia cells (Sikora et al., 1997) and BKS-2 B lymphoma cells (Han et al., 1999) more effectively than the primary thymocytes and normal splenic B cells, respectively.
The nuclear transcription factor kappa-B (NF-κB) is one of the most ubiquitous transcription factors that regulates the expression of distinct sets of genes that encode proteins involved in mediating cellular proliferation, inflammatory responses, cell adhesion, etc. The functionally active NF-κB exists mainly as a hetero-dimer consisting of subunits of the Rel family, which are normally sequestered in the cytosol as an inactive complex by binding to the inhibitory protein IκB. Phosphorylation and subsequent ubiquitination of IκB upon exposure of the cells to various extracellular stimuli causes rapid degradation of this inhibitory subunit by proteosomes. The resulting free NF-κB translocates to the nucleus, where it binds to the specific κB binding sites that are located in the promoter region of the target genes, thereby controlling their expression (Sen and Packer, 1996; Barnes et al., 1997) . NF-κB has dual functions in terms of regulating cell survival and apoptosis (Shishodia and Aggarwal, 2002) . Another transcription factor, activator protein-1 (AP-1), also has a central role in controlling the eukaryotic gene expression. AP-1 is composed of Jun and Fos proteins, which interact via a leucine-zipper domain. Like NF-κB, DNA binding of AP-1 is influenced by the cellular redox state (Abate et al., 1990; Sen and Packer, 1996) . AP-1 activation is required for TPAstimulated cellular proliferation and transformation. It is considered to be essential in tumor promotion (Angel and Karin, 1991; Huang et al., 1991; Dong et al., 1994; Li et al., 1997) .
Curcumin has multifaceted functions in influencing the expression of proteins that are involved in cellular proliferation, inflammation, adhesion, malignant transformation, etc. As part of our research program to elucidate the molecular mechanisms that underlie the pleiotropic actions of this chemopreventive phytochemical, we investigated its effects on the activation of two prototype eukaryotic transcription factors, NF-κB and AP-1.
Materials and Methods
Chemicals Curcumin and gentamycin were purchased from the Sigma Chemical Co. (St. Louis, USA). TPA was a product of Alexis Biochemicals (San Diego, USA). RPMI 1640 and fetal bovine serum were supplied from Gibco-BRL (Rockville, USA).
Preparation of cytosolic and nuclear extracts from HL-60 cells Unless otherwise specified, the HL-60 cells (1 × 10 7 ) were grown in a RPMI 1640 medium that was supplemented with 10% heatinactivated fetal bovine serum and gentamycin (5 µg). Cells were treated with dimethyl sulfoxide (DMSO) or TPA (10 nM) for 1 h. When necessary, varying concentrations of curcumin were added 30 min before the TPA treatment. Curcumin was dissolved in DMSO. The proportion of DMSO in the culture media did not exceed 0.5%. The control cells were treated with the same volume of solvent. The cells were lysed by incubation at 4 o C for 10 min in 400 µl of buffer A [10 mM HEPES (pH 7.9), 10 mM KCl, 0.2 mM EDTA, 1.5 mM MgCl 2 , 0.5 mM DTT, 0.2 mM phenylmethylsulfonyl fluoride (PMSF)]. The cell lysate was centrifuged for 6 min. The resulting pellet was resuspended in 100 µl of ice-cold buffer C [20 mM HEPES (pH 7.9), 420 mM NaCl, 1.5 mM MgCl 2 , 20% (v/v) glycerol, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF], followed by incubation at 4 o C for 20 min. After centrifugation, the supernatant was collected, aliquoted, and stored at −70 o C (Dent and Latchman, 1993) . The protein content of the final extracts was estimated using the BCA kit that was supplied from Bio-Rad (Richmond, USA), according to the manufacturers protocol.
Electrophoretic mobility shift assay (EMSA) EMSA was performed using a DNA-protein binding detection kit (Gibco-BRL; Rockville, USA) for the measurement of NF-κB binding, according to the manufacturer's protocol with minor modifications. Briefly, the double-strand NF-κB oligonucleotide was labeled with [γ-32 P]ATP by T4 polynucleotide kinase and purified on a Nick column (Pharmacia Biotech Inc., Buckinghamshire, UK). The binding reaction was carried out in 25 µl of a mixture that contained 5 µl of an incubation buffer [10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 4% (v/v) glycerol, and 0.1 mg/ml sonicated salmon sperm DNA], 10 µg of nuclear extract, and 100,000 cpm of the labeled probe. To verify the specificity of NF-κB, fifty-fold excess of unlabeled NF-κB oligonucleotide was added to the reaction mixture as a competitor. For the supershift assay, 2 µg of p50 or p65 antibody was added. After a 20-min incubation at room temperature, 2 µl of 0.1% bromophenol blue was added. The samples were then electrophoresed through a 6% nondenaturing polyacrylamide gel at 150 V at room temperature. Finally, the gel was dried and exposed to x-ray film. EMSA for AP-1 was carried out in the same manner as that for NF-κB, except that the AP-1 oligonucleotide (Promega, Madison, USA) was used as a probe (Kwon et al., 2001) .
Western blot analysis of p65 and IκBα Both the nuclear and cytosolic extracts that were prepared from the HL-60 cells were subjected to 12% SDS-polyacrylamide gel electrophoresis for measuring p65 and IκBα levels. After a 3-h transfer of the gel to the PVDF membrane (Amersham Life Sciences, Arlington Heights, USA), the blots were blocked with 5% fat-free dry milk in phosphate-buffered saline that contained 0.1% Tween-20 for 2 h at room temperature, then washed in the same buffer. The p65 protein was detected with a rabbit p65 polyclonal antibody (Santa Cruz Biotech., Santa Cruz, USA) that was diluted 1:2000. IκBα protein was detected with a rabbit IκBα polyclonal antibody (Santa Cruz Biotech, Santa Cruz, USA) that was diluted 1 : 1000. Goat anti-rabbit immunoglobulin G-conjugated horseradish peroxidase (diluted 1 : 5000) was used as a secondary antibody. The transferred proteins were visualized with an enhanced chemiluminescence (ECL) detection kit (Amersham Life Sciences, Arlington Heights, USA).
Results
TPA induces the activation of NF-κB in HL-60 cells in a dose-and time-related manner In order to investigate the effect of TPA on the activation of NF-κB, the HL-60 cells were incubated with various concentrations of TPA for 1 h, and EMSA was performed. The activation of NF-κB, as assessed in terms of its DNA binding activity, was evident when the cells were incubated with 1 nM TPA. The maximal NF-κB DNA binding was observed with 10 nM TPA ( Fig.  2A) . We then examined the kinetics of the TPA-induced activation of NF-κB in the same cell line after treatment with 10 nM TPA. As shown in Figure 2B , NF-κB activation peaked at 1 h, and decreased to the baseline level in 6 h.
One of the most predominant forms of NF-κB/Rel proteins is a heterodimer of p50 and p65 (Thanos and Maniatis, 1995) . In order to ascertain the specificity, as well as the identity of NF-κB in HL-60 cells, EMSA was performed with excess amounts of unlabeled NF-κB oligonucleotide for the competition assay and with antibodies against typical NF-κB subunits, p50 and p65, for the super-shift assay. As illustrated in Figure 2C , incubation of the TPA-stimulated nuclear extract with the 50-fold excess unlabeled NF-κB oligonucleotide before EMSA abolished the NF-κB DNA binding that was induced by TPA. This indicates that the retarded band that was observed in EMSA is indeed NF-κB. Incubation of TPAstimulated nuclear extracts with an antibody against either p50 or p65 shifted the band with the higher molecular weight (Fig.  2C) . These results indicate that the TPA-activated NF-κB complex in HL-60 cells exists as a heterodimer that consists of at least two typical NF-κB subunits, p50 and p65 proteins.
Curcumin inhibits TPA-induced NF-κB activation by blocking the degradation of IκBα and nuclear translocation of p65 subunits To examine whether curcumin could modulate TPA-induced NF-κB activation in the HL-60 cells, the cells were treated with various concentrations of curcumin for 30 min prior to the stimulation with 10 nM TPA for 1 h. TPA-induced NF-κB activation was significantly inhibited when the HL-60 cells were pretreated with 5 µM or 10 µM curcumin, while no significant effect was observed at 1 µM (Fig. 3A) . In an attempt to elucidate the mechanism that underlies the inhibitory effects of curcumin on TPA-induced NF-κB activation, we tested whether curcumin could block the TPA-induced degradation of IκBα and nuclear translocation of p65. As shown in Figure 3B , curcumin inhibited both processes in a concentrationdependent manner.
Curcumin suppresses the activation of AP-1 induced by TPA in HL-60 cells Besides NF-κB, AP-1 also plays a crucial role in the regulation of a vast variety of genes that are responsible for cell proliferation and differentiation. /ml) were treated with DMSO or curcumin (5 or 10 µM) for 30 min prior to stimulation with TPA (10 nM). Nuclear and cytosolic fractions were prepared 1 h later and subjected to an immunoblot analysis to detect p65 and IκBα, respectively. Lane 1, DMSO as a control; lane 2, TPA alone; lane 3, 1 µM curcumin + TPA; lane 4, 5 µM curcumin + TPA; lane 5, 10 µM curcumin + TPA. Abbreviations: NE, nuclear extract; CE, cytosolic extract. Therefore, we also examined the effect of curcumin on the DNA binding of AP-1. When the HL-60 cells were preincubated with various concentrations of curcumin, TPAinduced activation of AP-1 was inhibited in a concentrationdependent manner (Fig. 4 ). An almost complete inhibition of AP-1 activation was achieved with curcumin at a concentration as low as 1 µM (Fig. 4) .
Curcumin can also directly interrupt DNA binding of NF-κB and AP-1 to their consensus sequences In the previous experiment, curcumin was found to inhibit NF-κB activation by blocking IκBα degradation in the cytoplasm and translocation of p65 to the nucleus. Alternatively, curcumin could suppress NF-κB activation by directly interfering with the DNA binding of the functionally active subunit of NF-κB. To test this possibility, the nuclear extract that was isolated from the TPA-stimulated HL-60 cells was treated with 10 µM curcumin in vitro, and EMSA was conducted. Curcumin directly inhibited the ability of NF-κB to bind DNA (Fig. 5A) . Likewise, the direct DNA binding capability of AP-1 was repressed by addition of curcumin to the EMSA mixture containing preactivated nuclear extracts (Fig. 5B) .
Discussion
Recent advances in our understanding of the biochemical and molecular basis of inflammatory processes reveal that the transcription factors NF-κB and AP-1 are implicated in the inducible expression of a wide array of genes in response to proinflammatory cytokines, reactive oxygen species, and mitogens (Chabot-Fletcher, 1996; Sen and Packer, 1996) . Since intracellular signaling pathways that lead to the activation of NF-κB and AP-1 may differ from one cell type to another, and depend on the types and duration of stimuli (Angel and Karin, 1991; Johnson et al., 1996) , we initially tried to assess whether or not the classical tumor promoter TPA can activate NF-κB and AP-1 in the HL-60 cells, as it does in other cell lines. Our results show that TPA rapidly and transiently induces the activation of the former transcription factor. NF-κB that was activated in the TPA-stimulated HL-60 cells was found to consist of p65 and p50 subunits.
There is accumulating evidence that the activation of NF-κB is pivotal in regulating the expression of proteins that are associated with tumor promotion, which is suppressed by some chemopreventive agents, including curcumin (Singh and Aggarwal, 1995; Natarajan et al., 1996; Bierhous et al., 1997; Plummer et al., 1999; Surh et al., 2000) . Therefore, we found that curcumin inhibits the activation of this transcription factor in TPA-treated HL-60 cells. Since the translocation of p65 to the nucleus is preceded by the phosphorylation and degradation of IκBα in the cytoplasm (Remacle et al., 1995; Thanos and Maniatis, 1995) , we also determined whether or not curcumin could inhibit the nuclear translocation of p65 by preventing the degradation of the inhibitory protein IκBα. Our results reveal that curcumin does inhibit the TPA-induced NF-κB activation by preventing the degradation of IκBα and subsequent translocation of the p65 subunit, which agrees with previously reported findings (Singh et al., 1996; Jobin et al., 1999) . Curcumin completely blocks the TPA-and bacterial lipopolysaccharide-induced activation of NF-κB in endothelial cells (Pendurthi et al., 1997) . Curcumin also prevents the tumor necrosis factor-α (TNF-α)-induced NF-κB activation by inhibiting the phosphorylation and degradation of IκB in human myelomonoblastic leukemia cells (Singh and Aggarwal, 1995) . According to Pendurthi et al. (1997) , the TNF-α-induced activation of NF-κB was suppressed by curcumin through the blockade of the degradation of IκBα and subsequent activation of p65 in endothelial cells. Likewise, curcumin inhibited the interleukin-1β-mediated phosphorylation and subsequent degradation of IκBα in rat intestinal epithelial cells, which led to the inactivation of NF-κB (Jobin et al., 1999) . Therefore, it seems likely that curcumin regulates the upstream pathway(s) of IκBα phosphorylation, thereby preventing IκBα degradation, which results in the repression of NF-κB activation (Jobin et al., 1999; Pan et al., 2000) . Additional studies will be necessary in order to determine whether or not curcumin can suppress the activation of mitogen-activated protein kinases, which in turn blocks the phosphorylation of IκBα through the downregulation of IκB kinase. Curcumin may also affect the ubiquitination and proteosome-mediated degradation of IκBα. Evidence supports the roles of reactive oxygen intermediates as common and critical regulators in the activation of NF-κB (Eicher et al., 1994; Koong et al., 1994) . In consideration of the strong antioxidant activity that curcumin retains, it is conceivable that this compound inhibits NF-κB activation by scavenging reactive oxygen species that are generated in the TPA-stimulated HL-60 cells.
AP-1 is another well-defined transcription factor that is known to be regulated by the intracellular redox state. It is involved in the inducible expression of a wide variety of genes. The functional activation of AP-1 may play a pivotal role in the signal transduction mediating TPA-induced cellular proliferation and malignant formation. The binding site of AP-1 on DNA is recognized as the TPA response element (TRE) that is present in the promoter region of several genes, including the metallothioneine IIA gene, collagenase, interleukin-2, etc. (Abate et al., 1990; Sen and Packer, 1996) . Besides the NF-κB activation, the activation of AP-1 that is induced by TPA in HL-60 cells was also inhibited by curcumin. Curcumin also inhibits the TPA-induced TRE binding of c-Jun/AP-1 in mouse fibroblast cells (Huang et al., 1991) . Curcumin down-regulates AP-1 activation in the human breast tumor cell line (Mehta et al., 1997) and the TPA-induced AP-1 activation in mouse skin . Apoptotic death in dexamethasone-treated rat thymocytes and UV-irradiated Jurkat cells was suppressed by curcumin, which was accompanied by the inhibition of AP-1 DNA binding activity in these cells (Sikora et al., 1997) . Similarly, bufalin-induced apoptosis in human leukemia U937 cells was attenuated by curcumin, which appeared to be mediated through the inactivation of AP-1 (Watabe et al., 1998) . Curcumin was recently reported to inhibit the TNF-α-induced binding of AP-1 to DNA in bovine aortic endothelial cells (Bierhaus et al., 1997) .
In addition to blocking the degradation of the IκBα and p65 translocation to nucleus, curcumin also directly inhibited the binding of NF-κB and AP-1 to their consensus sequences on DNA. Since curcumin has two α,β-unsaturated ketone moieties, the compound may covalently interact with the nucleophilic sites of NF-κB and AP-1 transcription factors through the Michael addition, thereby hampering their DNA binding.
In conclusion, our findings indicate that curcumin suppresses the TPA-stimulated activation of NF-κB and AP-1. This may contribute to the anti-tumor promoting properties this chemopreventive phytochemical retains.
